ABBOTT INDIA LIMITED
- Country
- 🇮🇳India
- Ownership
- Private
- Established
- 1888-01-01
- Employees
- 73K
- Market Cap
- $7.5B
- Website
- http://www.abbott.com
Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-related Pain
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Abbott
- Target Recruit Count
- 250
- Registration Number
- NCT06952296
Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia
- Conditions
- Functional Dyspepsia
- Interventions
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 564
- Registration Number
- NCT06217393
- Locations
- 🇻🇳
103 Military Hospital, Hanoi, Vietnam
🇻🇳Bach Mai Hospital, Hanoi, Vietnam
🇦🇲"Grigor Narekatsi" MC, CJSC, Yerevan, Armenia
Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy Human Adult Subjects
- Conditions
- Healthy SubjectsHuman VolunteersHealthy ParticipantsBioequivalence
- Interventions
- First Posted Date
- 2022-08-29
- Last Posted Date
- 2022-08-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 56
- Registration Number
- NCT05519514
- Locations
- 🇮🇳
Study Site, Mangalore, India
A Clinical Study to Evaluate the Effect of Mobile Applications "My A:Care" and "Smart Coach" on the Lipid-lowering Treatment Adherence of Subjects With Dyslipidemia in Thailand
- Conditions
- Dyslipidemia
- Interventions
- Behavioral: Smart Coach
- First Posted Date
- 2022-05-11
- Last Posted Date
- 2023-02-15
- Lead Sponsor
- Abbott
- Target Recruit Count
- 150
- Registration Number
- NCT05370703
- Locations
- 🇹🇭
Chatlert Mueang Pongchaiyakul, Khon Kaen, Thailand
Bioequivalence Study of Moksi® 400mg Tablet and Avelox® 400mg Tablet (Moxifloxacin) Under Fasting Condition in Healthy Adult Pakistani Subjects
- Conditions
- Bioequivalence
- Interventions
- Drug: Moksi® 400mg Tablet
- First Posted Date
- 2022-04-01
- Last Posted Date
- 2022-04-01
- Lead Sponsor
- Abbott
- Target Recruit Count
- 38
- Registration Number
- NCT05307614
- Locations
- 🇵🇰
Center for Bioequivalence Studies and Clinical Research (CBSCR) ICCBS, University of Karachi, Karachi, Sindh, Pakistan
Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bowel Disorders
- Conditions
- Functional Bowel Disorder
- Interventions
- First Posted Date
- 2022-01-03
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Abbott
- Target Recruit Count
- 465
- Registration Number
- NCT05175131
- Locations
- 🇷🇺
Null Research Facilities, Moscow, Russian Federation
A Study to Determine the Validity and Sensitivity of 'Questionnaire to Screen for HYpothyroidism' (Q'SHY)
- Conditions
- HypothyroidismHealthy
- Interventions
- Diagnostic Test: Blood test for Thyroid stimulating hormone (TSH)
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2022-07-13
- Lead Sponsor
- Abbott
- Target Recruit Count
- 232
- Registration Number
- NCT04784208
- Locations
- 🇮🇳
Center for Diabetes and Endocrine care, Bangalore, India
🇮🇳Apollo Excelcare Hospital, Guwahati, India
🇮🇳Healthy Lifestyle Clinic, Kolkata, India
An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.
- Conditions
- Hypertriglyceridemia
- Interventions
- Drug: Omega-3-acid ethyl ester or Placebo
- First Posted Date
- 2021-02-16
- Last Posted Date
- 2021-03-05
- Lead Sponsor
- Abbott
- Target Recruit Count
- 248
- Registration Number
- NCT04756180
Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrome (TRISTAN)
- Conditions
- HypertriglyceridemiaMetabolic Syndrome
- Interventions
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2021-12-15
- Lead Sponsor
- Abbott
- Target Recruit Count
- 1000
- Registration Number
- NCT04650152
- Locations
- 🇷🇺
Clinical hospital, Samara, Russian Federation
🇷🇺Clinical Diagnostic Centre, Bryansk, Russian Federation
🇷🇺Dispensary, Krasnoyarsk, Russian Federation
Predictors of Pregnancy Rate in Assisted Reproductive Technology According to Actual Guidelines
- Conditions
- Infertility
- Interventions
- First Posted Date
- 2020-01-30
- Last Posted Date
- 2021-12-28
- Lead Sponsor
- Abbott
- Target Recruit Count
- 1150
- Registration Number
- NCT04249297
- Locations
- 🇰🇿
PERSONA International Clinical Center for Reproductology, Almaty, Kazakhstan
🇷🇺ART Department Irkutsk Regional Clinical Hospital, Irkutsk, Russian Federation
🇷🇺Reproduction Clinic ' Philosophy of Life', Perm, Russian Federation